Cited by 251Mitochondrial Function and PathologyCell death mechanisms and regulationAutophagy in Disease and Therapy

Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines

Zhao, Kesheng, Luo, Guoxiong, Giannelli, Serena, Szeto, Hazel H.·2005·Biochemical Pharmacology

Abstract

Oxidative stress and mitochondrial oxidative damage have been implicated in aging and many common diseases. Mitochondria are a primary source of reactive oxygen species (ROS) in the cell, and are particularly susceptible to oxidative damage. Oxidative damage to mitochondria results in mitochondrial permeability transition (MPT), mitochondrial depolarization, further ROS production, swelling, and release of cytochrome c (cyt c). Cytosolic cyt c triggers apoptosis by activating the caspase cascade. In the present work, we examined the ability of a novel cell-penetrating, mitochondria-targeted peptide antioxidant in protecting against oxidant-induced mitochondrial dysfunction and apoptosis in two neuronal cell lines. Treatment with tert-butyl hydroperoxide (tBHP) for 24 h resulted in lipid peroxidation and significant cell death via apoptosis in both N2A and SH-SY5Y cells, with phosphatidylserine translocation, nuclear condensation and increased caspase activity. Cells treated with tBHP showed significant increase in intracellular ROS, mitochondrial depolarization and reduced mitochondrial viability. Concurrent treatment with <1 nM SS-31 (D-Arg-Dmt-Lys-Phe-NH2; Dmt = 2',6'-dimethyltyrosine) significantly decreased intracellular ROS, increased mitochondrial potential, and prevented tBHP-induced apoptosis. The remarkable potency of SS-31 can be explained by its extensive cellular uptake and selective partitioning into mitochondria. Intracellular concentrations of [3H]SS-31 were 6-fold higher than extracellular concentrations. Studies using isolated mitochondria revealed that [3H]SS-31 was concentrated approximately 5000-fold in the mitochondrial pellet. By concentrating in the inner mitochondrial membrane, SS-31 is localized to the site of ROS production, and can therefore protect against mitochondrial oxidative damage and further ROS production. SS-31 represents a novel platform of mitochondria-targeted antioxidants with broad therapeutic potential.

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2005.08.022

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SS-31 protects neuronal cells against tert-butyl-hydroperoxide (tBHP) induced mitochondrial depolarization and apoptotic cell death by reducing intracellular ROS, decreasing markers of apoptotic cell death and caspase activity.

    “SS-31 protects neuronal cells against tert-butyl-hydroperoxide (tBHP) induced mitochondrial depolarization and apoptotic cell death by reducing intracellular ROS, decreasing markers of apoptotic cell death and caspase activity177.”

    From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [177]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhao, K., Luo, G., Giannelli, S., & Szeto, H. H.
Affiliations
Cornell University (US)
Corresponding author
Szeto, Hazel H.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2005-12
Volume
70
Issue
12
Pages
1796-1806
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2032478715
Cited by
251
References
49
Citations by year
2026: 7 · 2025: 12 · 2024: 16 · 2023: 19 · 2022: 13 · 2021: 15 · 2020: 9 · 2019: 13 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 19 · 2012: 7
FWCI
3.39
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Drug Abuse (DA08924, P01DA008924)
  • National Institute of Neurological Disorders and Stroke (R21NS048295, NS-48295)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
mitochondria-targeted peptide, SS-31, tert-butyl hydroperoxide, oxidative stress, mitochondrial depolarization, apoptosis, reactive oxygen species, mitochondrial permeability transition, cytochrome c release, lipid peroxidation, neuronal cell lines, N2a cells, SH-SY5Y cells, caspase activation, mitochondrial membrane potential
MeSH terms
Mitochondrial Permeability Transition Pore, Antioxidants, Cell Line, Humans, Ion Channels, Mitochondria, Neurons, Oligopeptides, Lipid Peroxidation, Apoptosis, Reactive Oxygen Species, tert-Butylhydroperoxide, Caspases, Mitochondrial Membrane Transport Proteins, Caspase 9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review